<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03479463</url>
  </required_header>
  <id_info>
    <org_study_id>AFSUR003</org_study_id>
    <nct_id>NCT03479463</nct_id>
  </id_info>
  <brief_title>Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy</brief_title>
  <official_title>A Matched Case Clinical Registry - Efficacy of AmnioFix in the Prevention of Post-Operative Salivary Leaks Following Head and Neck Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MiMedx Group, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MiMedx Group, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial aims to determine if intra-operative use of human dehydrated amnion chorion
      allograft improves post-operative patient healing outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 19, 2018</start_date>
  <completion_date type="Anticipated">July 19, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 19, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>150 Days</target_duration>
  <primary_outcome>
    <measure>Incidence of PCF Development</measure>
    <time_frame>60 days</time_frame>
    <description>Incidence of PCF developement necessitating intervention within the 60 day time point.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Larynx Cancer</condition>
  <condition>Pharynx Cancer</condition>
  <condition>Pharyngocutaneous Fistula</condition>
  <arm_group>
    <arm_group_label>Treatment with Dehydrated Human Amnion Chorion Allograft</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Dehydrated human amnion/chorion membrane</intervention_name>
    <description>Laryngectomy/pharyngectomy patched with dehydrated human amnion chorion allograft</description>
    <arm_group_label>Treatment with Dehydrated Human Amnion Chorion Allograft</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is a single-center, matched case registry. The medical records of approximately 40
        patients meeting all documentation and eligibility requirements will comprise the
        retrospective cohort. A total of 40 subjects will be enrolled prospectively at Mount Sinai
        Hospital. It is expected that the majority of the subjects will be recruited through the
        investigators' standard admission practices. The estimated enrollment period is 16 months
        with data collection at a baseline pre-operative visit, throughout the length of
        hospitalization, and intermittently through outpatient follow-up visits up to 60 days from
        the date of the index surgery. All subjects selected for the study will not be excluded
        because of race or ethnicity and all efforts will be made to adequately represent the
        patient population in the area in which they are chosen.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is scheduled to undergo laryngectomy and/or pharyngectomy procedure due to
             oncological indication

          2. Subject is age 18 or older

          3. Subject is willing and able to provide informed consent and participate in all
             procedures and follow-up evaluations necessary to complete the study

        Exclusion Criteria:

          1. Subjects currently enrolled in or planning to enroll in another clinical trial

          2. Subjects with a known history of poor compliance with medical treatments

          3. Subjects that are using or have used an investigational drug, device, or biologic
             within the 12 weeks prior to treatment

          4. Subjects that have any significant medical condition(s) that, in the opinion of the
             Investigator, would interfere with protocol evaluation and participation

          5. Subject has undergone previous pharyngeal reconstructive surgery

          6. Pregnancy at enrollment or within last 6 months, women who are breastfeeding, or women
             of childbearing potential who are planning to become pregnant during the time of the
             study OR are unwilling/unable to use acceptable methods of contraception (birth
             control pills, barriers, or abstinence)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brett Miles, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Hospital, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029-6574</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2018</study_first_posted>
  <last_update_submitted>April 2, 2018</last_update_submitted>
  <last_update_submitted_qc>April 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Laryngeal Neoplasms</mesh_term>
    <mesh_term>Pharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

